| Ms Michele Patricia Megregian, CNM | |
|
3181 Sw Sam Jackson Park Rd, Kpv7c, Portland, OR 97239-3011 | |
| (503) 418-4500 | |
| Not Available |
| Full Name | Ms Michele Patricia Megregian |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 3181 Sw Sam Jackson Park Rd, Portland, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043206279 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 209-001428 (Illinois) | Secondary |
| 367A00000X | Advanced Practice Midwife | 200850062NP (Oregon) | Primary |
| Entity Name | University Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376709535 PECOS PAC ID: 4880760107 Enrollment ID: O20080910000013 |
News Archive
comScore, Inc., a leader in measuring the digital world, today released the results of a study of changes in search engine marketing in the pharmaceutical industry as a result of the FDA warning letters distributed in March 2009.
In an attack of hay fever, the temperature of the nose rises. Effective medication prevents this too. An infrared camera provides non-contact images of the changes. Researchers can use these images to determine how reliable and effective anti-allergic agents are.
Nektar Therapeutics today announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is Nektar's investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers.
Clinicians need to be sensitive and aware of the unique challenges of women's reproductive health needs in times of conflict, suggests a new review published today (4 July) in The Obstetrician & Gynaecologist.
› Verified 9 days ago
| Entity Name | Tuality Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073929782 PECOS PAC ID: 7416173414 Enrollment ID: O20140729000238 |
News Archive
comScore, Inc., a leader in measuring the digital world, today released the results of a study of changes in search engine marketing in the pharmaceutical industry as a result of the FDA warning letters distributed in March 2009.
In an attack of hay fever, the temperature of the nose rises. Effective medication prevents this too. An infrared camera provides non-contact images of the changes. Researchers can use these images to determine how reliable and effective anti-allergic agents are.
Nektar Therapeutics today announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is Nektar's investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers.
Clinicians need to be sensitive and aware of the unique challenges of women's reproductive health needs in times of conflict, suggests a new review published today (4 July) in The Obstetrician & Gynaecologist.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Michele Patricia Megregian, CNM 3415 Se 8th Ave, Portland, OR 97202-2708 Ph: (847) 826-5467 | Ms Michele Patricia Megregian, CNM 3181 Sw Sam Jackson Park Rd, Kpv7c, Portland, OR 97239-3011 Ph: (503) 418-4500 |
News Archive
comScore, Inc., a leader in measuring the digital world, today released the results of a study of changes in search engine marketing in the pharmaceutical industry as a result of the FDA warning letters distributed in March 2009.
In an attack of hay fever, the temperature of the nose rises. Effective medication prevents this too. An infrared camera provides non-contact images of the changes. Researchers can use these images to determine how reliable and effective anti-allergic agents are.
Nektar Therapeutics today announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is Nektar's investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers.
Clinicians need to be sensitive and aware of the unique challenges of women's reproductive health needs in times of conflict, suggests a new review published today (4 July) in The Obstetrician & Gynaecologist.
› Verified 9 days ago
Margaret R. Zak, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 9340 Sw Barnes Road, The Prenatal Clinic, Suite 102, Portland, OR 97225 Phone: 503-216-2859 | |
Margaret Elizabeth Shaw, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-4500 | |
Elise N Erickson, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 9427 Sw Barnes Rd, Suite 395, Portland, OR 97225 Phone: 503-216-2602 | |
Olivia Kroening-roche, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-7591 Fax: 503-494-7591 | |
Polly C Molden, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-418-4500 Fax: 503-494-1678 | |
Kelsey Tassinari Poppe, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3455 Sw Us Veterans Hospital Rd, Portland, OR 97239 Phone: 503-494-7725 | |
Ms. Barbara O'malley Floyd, CNM, NMNP Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3231 Se 50th Ave, Portland, OR 97206 Phone: 503-775-4931 Fax: 503-788-7285 |